Results 1 to 10 of about 118,306 (318)

Infiltrative Cardiomyopathies [PDF]

open access: yesClinical Medicine Insights: Cardiology, 2015
Infiltrative cardiomyopathies can result from a wide spectrum of both inherited and acquired conditions with varying systemic manifestations. They portend an adverse prognosis, with only a few exceptions (ie, glycogen storage disease), where early ...
David Bejar   +3 more
doaj   +4 more sources

Mitochondrial cardiomyopathies [PDF]

open access: yesFrontiers in Cardiovascular Medicine, 2016
Mitochondria are found in all nucleated human cells and perform a variety of essential functions, including the generation of cellular energy. Mitochondria are under dual genome control.
Ayman W. El-Hattab, Fernando Scaglia
doaj   +3 more sources

Reversible Cardiomyopathies

open access: yesClinical Medicine Insights: Cardiology, 2015
Cardiomyopathies (CMs) have many etiological factors that can result in severe structural and functional dysregulation. Fortunately, there are several potentially reversible CMs that are known to improve when the root etiological factor is addressed.
Harsh Patel   +4 more
doaj   +4 more sources

Survival of patients with cardiomyopathies [PDF]

open access: yesБългарска кардиология, 2021
Cardiomyopathies are a heterogeneous group of diseases. The main pathogenetic mechanism is myocardial damage due to genetic mutations. Cardiomyopathies are one of the leading causes of heart failure, sudden cardiac death, and life-threatening arrhythmias.
Monika Shumkova   +4 more
doaj   +3 more sources

Non Coding RNAs as Regulators of Wnt/β-Catenin and Hippo Pathways in Arrhythmogenic Cardiomyopathy

open access: yesBiomedicines, 2022
Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiomyopathy histologically characterized by the replacement of myocardium by fibrofatty infiltration, cardiomyocyte loss, and inflammation.
Marina Piquer-Gil   +5 more
doaj   +1 more source

Expanding the deep-learning model to diagnosis LVNC: Limitations and trade-offs [PDF]

open access: yesComputer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization. 2024, 2023
Hyper-trabeculation or non-compaction in the left ventricle of the myocardium (LVNC) is a recently classified form of cardiomyopathy. Several methods have been proposed to quantify the trabeculae accurately in the left ventricle, but there is no general agreement in the medical community to use a particular approach.
arxiv   +1 more source

Re-Definition of the Epidemiology of Cardiac Amyloidosis

open access: yesBiomedicines, 2022
The epidemiology of cardiac amyloidosis (CA), traditionally considered a rare and incurable disease, has changed drastically over the last ten years, particularly due to the advances in diagnostic methods and therapeutic options in the field of ...
Maddalena Rossi   +9 more
doaj   +1 more source

Takotsubo is not a cardiomyopathy [PDF]

open access: yesInternational Journal of Cardiology, 2018
Unraveling the mechanisms underlying Takotsubo (TTS) leads to question the current inclusion of the condition within the spectrum of cardiomyopathies. Indeed, the clinical presentation and pathophysiology of TTS clearly differ from cardiomyopathies, i.e.
Francesco Pelliccia   +5 more
openaire   +9 more sources

Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination

open access: yesFrontiers in Cardiovascular Medicine, 2021
Background: The prevalence of cardiac amyloidosis (CA) is unknown.Aims and Methods: We sought to (a) determine the prevalence of CA in unselected patients ≥75 years undergoing autopsy, (b) characterize cardiological profiles of CA and non-CA patients by ...
Aldostefano Porcari   +6 more
doaj   +1 more source

Cardiomyopathies: An Overview [PDF]

open access: yesInternational Journal of Molecular Sciences, 2021
Background: Cardiomyopathies are a heterogeneous group of pathologies characterized by structural and functional alterations of the heart. Aims: The purpose of this narrative review is to focus on the most important cardiomyopathies and their epidemiology, diagnosis, and management. Methods: Clinical trials were identified by Pubmed until 30 March 2021.
Ciarambino T.   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy